Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Greenwich LifeSciences, Inc. (GLSI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Revenue          
Operating expenses          
Research and development   6.56.15.04.93.62.11.6
General and administrative   1.61.41.01.01.01.31.2
    Total operating expenses   8.07.56.06.04.63.42.8
    Loss from operations   -8.0-7.5-6.0-6.0-4.6-3.4-2.8
Interest Income   0.20.10.10.00.00.00.0
    Net loss   -7.8-7.4-5.9-5.9-4.6-3.4-2.8
   
Per share information:          
Net loss per common share, basic   ($0.61)($0.57)($0.46)($0.46)($0.36)($0.30)($0.26)
Net loss per common share, diluted   ($0.61)($0.57)($0.46)($0.46)($0.36)($0.30)($0.26)
Weighted average common shares outstanding, basic   38.738.939.139.038.838.725.7
   
Weighted average common shares outstanding, diluted     3.2    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy